Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors
Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors
Active, not recruiting · NCT03964727 · Registry updated 2026-04-28Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study of Sacituzumab Govitecan in Participants With Metastatic Solid Tumors | Neoplasm Metastasis, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Active, not recruiting | Phase 2 | 2026-04-28 | NCT03964727 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Gilead Sciences | 180 |
65 results · Page 1 of 3
Research sites
Swipe the table sideways for more columns.